Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2156 results

Companies settle trade secret dispute over anaesthetic ingredient


Drugmaker Genus Lifesciences and pharmaceutical company Mallinckrodt have agreed to settle their trade secret dispute related to a cocaine hydrochloride formulation.

Novartis, Dana-Farber seek to bar generic leukaemia drug

US09-06-2022Muireann Bolger

Novartis Pharmaceuticals and the Dana-Farber Cancer Institute have filed two lawsuits to bar generic versions of leukaemia drug, Rydapt.

Senators urge USPTO to curb ‘patent thicket’ abuse


A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.

J&J units launch prostate cancer drug suit

US31-05-2022Sarah Speight

Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

USPTO urges Vidal review of Arthrex petition

US19-05-2022Muireann Bolger

The US Patent and Trademark Office has argued against a bid by medical device maker Arthrex, which wants recognition that an ex-interim acting director lacked the power to refuse to review its petition.

Moderna aims to offset COVID vaccine lawsuit to US govt

US10-05-2022Legal developmentsMuireann Bolger

Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.

AstraZeneca says Mylan, Kindeva infringe another Symbicort patent

US28-04-2022Alex Baldwin

AstraZeneca filed a patent infringement lawsuit against Mylan Pharmaceuticals and Kindeva Drug Delivery on Tuesday, claiming that their generic asthma Symbicort infringes a brand-new patent that was issued the same day.

Akerman brings in healthcare patent litigator Jeffrey Toney


Akerman has hired Atlanta-based patent litigator Jeffrey Toney from McDermott Will & Emery.

Alkermes and Janssen enter arbitration over nanocrystal tech

US21-04-2022Alex Baldwin

Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson subsidiary Janssen Pharmaceuticals.

SCOTUS asks for SG’s view on enablement in antibody dispute

US19-04-2022Muireann Bolger

The US Supreme Court has asked the Solicitor General to wade in on a case centring on the legal concept of enablement that is the crux of an antibody patent dispute between Amgen and Sanofi.

Showing 1 to 10 of 2156 results